SENATE PASSES 30-DAY DELAY!
30-day partial extension signed into law September 2, 2026.
UPDATED SEPTEMBER 3, 2026
The 30-day partial hemp extension is now federal law. Most changes to the federal hemp definition—including the total-THC standard and 0.4 mg-per-container limit—are postponed until December 11, 2026. Restrictions involving cannabinoids that cannot naturally be produced by the cannabis plant still begin November 12, 2026. This temporary extension does not repeal Section 781 or establish a permanent regulatory framework.
Federal rules affecting hemp access are changing, and enforcement of updated hemp definitions is scheduled to begin
December 11, 2026
These changes may impact the availability, formulation, and legality of many hemp-derived wellness products that millions of Americans use every day.
This page explains what’s changing, who it affects, and how you can make your voice heard.
THE CLOCK IS TICKING!
November 12, 2026: Products containing lab-created cannabinoids that the cannabis plant cannot naturally produce lose their federal hemp status. This is narrower than all “synthetic” or converted cannabinoids.
December 11, 2026: The broader restrictions take effect, including rules affecting naturally occurring cannabinoids manufactured outside the plant, the total-THC standard and the 0.4 mg-per-container limit.
What about hemp seeds?
Hemp foods, including hemp hearts, grain, seed oil and protein - are not the target of the new cannabinoid restrictions. However, beginning December 11, 2026, viable planting seeds from cannabis plants exceeding 0.3% total THC, including THCA, may no longer qualify as federal hemp. Seeds used solely for lawful industrial-hemp production remain expressly included.
PASS THE DELAY. REGULATE - DON’T ELIMINATE - HEMP ACCESS.
Congress needs to hear directly from patients, caregivers, farmers, retailers, consumers, and small-business owners.
Contact your U.S. representative and senators today. Ask them to preserve the Senate’s 30-day delay in the final government funding measure and support responsible federal regulation of hemp-derived products.
When you reach out, you can say:
“Please preserve the Senate-approved 30-day hemp delay in the final government funding measure. I also urge Congress to establish responsible regulations that protect consumers without eliminating access to full-spectrum CBD and other lawful hemp-derived products. Patients, farmers, and small businesses need regulation—not prohibition.”
CALL & EMAIL
Calls count 1000 times more and only take 2 minutes to make. We love this resource provided by Charlotte's Web.
WHAT ELSE YOU CAN DO RIGHT NOW!
WRITE YOUR STORY
Write down how hemp supports your daily life. How does it help you or your loved ones?
SHARE!
Share on social media and in person why access matters to your health, stability or family.
CONTACT OFFICIALS
Share your personal story with local, state and federal officials. They need to hear the human stories and not just from lobbyists.
FIND YOUR REPRESENTATIVES HERE!
Get the names and contact information for the people who represent you on the federal, state, and local levels. https://www.usa.gov/elected-officials
If access to plant-based wellness has made your life safer, easier, or more manageable, now is the moment to say so. Policies are shaped by the voices that show up.
WHAT CHANGED?
In November 2025, Congress enacted Public Law 119-37, which changes the federal definition of hemp beginning November 12, 2026, unless Congress acts before then.
The amended law changes the plant and material standard from delta-9 THC alone to total THC, including THCA. It also excludes final hemp-derived cannabinoid products containing more than 0.4 milligrams of combined total THC and similarly acting cannabinoids per container.
Certain cannabinoids synthesized or manufactured outside the plant are also excluded. Industrial hemp grown for fiber, grain, seed oil, research, and other non-cannabinoid uses remains expressly included.
THE RESULT
If the law takes effect unchanged, many intoxicating hemp products and numerous non-intoxicating full-spectrum CBD products could fall outside the federal definition of hemp. Products that comply with the new thresholds would remain federally classified as hemp.
WHAT'S AT STAKE?
Consumers
Hemp products are more than “wellness trends.” For many, they are medicine, relief, self-care, and survival.
Those at risk include:
-
People managing chronic pain or inflammation
-
Veterans or trauma survivors using hemp for PTSD or anxiety
-
Patients relying on hemp/CBD for nausea, sleep, chronic illness, or cancer recovery support
-
Older adults using hemp for joint pain, sleep, wellness
-
People living in states without regulated cannabis markets — relying solely on hemp
-
Parents and caregivers turning to hemp rather than pharmaceuticals
When hemp-derived cannabinoids go illegal, it isn’t just a product that’s lost. It’s access to relief, to safety, to health, to dignity.
Jobs and the Economy
Hemp and hemp-derived cannabinoids are not just wellness products; they are part of a broader economic ecosystem:
-
The hemp-derived cannabinoid market is valued at over $28 billion in annual consumer demand.
-
This sector supports approximately 328,000 American jobs across farming, processing, manufacturing, retail, and distribution.
-
In states such as Texas, the hemp economy has been linked to tens of thousands of jobs and billions in local retail revenue.
Shifts in regulatory definitions can ripple through entire supply chains, affecting farmers, small businesses, storefronts, testing laboratories, and more.
Public Opinion
Public support for access to plant-based cannabinoids remains strong. A majority of U.S. adults — about 70% — support legal access to cannabis in some form, reflecting broad acceptance of plant-derived wellness choices.
While hemp and cannabis are regulated differently, these trends show that most Americans view access to plant-based products as a mainstream wellness issue.
.png)
A FEW TALKING POINTS & RESOURCES
